Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Re: The RANZCP position statement on gender dysphoria.
Zwickl S, Chaplin B, Bisshop F, Cook T, Soo CTM, Birtles B, Veale J, Carroll R, Johnson R, Macdonald J, Porter J, Withey-Rila C, Kristensen Z, Lin A. Zwickl S, et al. Among authors: bisshop f. Aust N Z J Psychiatry. 2022 Oct;56(10):1217-1218. doi: 10.1177/00048674221112007. Epub 2022 Jul 10. Aust N Z J Psychiatry. 2022. PMID: 35815707 No abstract available.
"Ever since I knew I was trans I knew I wanted hormone therapy": a qualitative exploration into the journey of Australian trans individuals accessing feminizing gender-affirming hormone therapy.
Fowler JA, Warzywoda S, Franks N, Bisshop F, Wood P, Dean JA. Fowler JA, et al. Among authors: bisshop f. Int J Transgend Health. 2023 Dec 11;25(4):840-854. doi: 10.1080/26895269.2023.2290132. eCollection 2024. Int J Transgend Health. 2023. PMID: 39465078 Free PMC article.
What you need to know about gender-affirming healthcare.
Carroll R, Bisshop F. Carroll R, et al. Among authors: bisshop f. Emerg Med Australas. 2022 Jun;34(3):438-441. doi: 10.1111/1742-6723.13990. Epub 2022 Apr 21. Emerg Med Australas. 2022. PMID: 35448915 Free PMC article. No abstract available.
Dolutegravir/Lamivudine Efficacy and Safety Outcomes in People With HIV-1 With or Without Historical Resistance Results at Screening: 48-Week Pooled Analysis.
Scholten S, Cahn P, Portilla J, Bisshop F, Hodder S, Ruane P, Kaplan R, Wynne BR, Man CY, Grove R, Wang R, Jones B, Ait-Khaled M, Kisare M, Okoli C. Scholten S, et al. Among authors: bisshop f. Open Forum Infect Dis. 2024 Jul 1;11(7):ofae365. doi: 10.1093/ofid/ofae365. eCollection 2024 Jul. Open Forum Infect Dis. 2024. PMID: 39015350 Free PMC article. Clinical Trial.
20 results